ENOV Earnings

ENOV reported its earnings on 2026-02-26, showcasing a revenue of against an estimate of 584.01M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.81 by 0%. The stock experienced a 13.89% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following ENOV's earnings announcement on 2026-02-26, the stock price moved by 13.89% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, ENOV's stock price tends to shift by an average of 3.41% in the 10 days leading up to earnings and -0.68% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ENOV's annual revenue to reach 582.64M, while the EPS is projected at 0.76. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ENOV's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ENOV's stock price typically moves by 3.41% in the 10 days before its earnings and -0.68% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.76 and revenue of 582.64M.

The company reported strong financial performance with a 10% YoY revenue growth, improved gross margins, and increased net income. Despite the lack of specific shareholder return plans, the positive guidance adjustments for revenue, EBITDA, and EPS indicate optimism. The absence of concerning Q&A responses further supports a positive outlook. Given the market cap of approximately $2.46 billion, the stock is likely to experience a positive reaction, falling in the 2% to 8% range over the next two weeks.